Scientists have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of damaged nerves after spinal trauma. The announcement comes weeks after the same research team showed a different investigational drug can reduce damage after spinal cord injury, by blocking the inflammatory response.